Aquarius Surgical Technologies Inc. develops and markets surgical technologies in Canada and the U.S. The company shows strengths in its gross margin of 48.6%, indicating potential profitability on sales; however, it faces significant concerns with an extremely low current ratio of 0.05 and negative EBITDA and net margins, suggesting severe liquidity issues and operational inefficiencies. The sharp price increase of 50% today may reflect speculative trading rather than fundamental improvement, as the overall financial health score is low at 22/100.
Loading financial metrics...
Company has $10K in cash but burned $43K last quarter. At this burn rate, only 0.2 quarters of runway remain without additional financing.
Revenue fell 31.8% year-over-year from $110K to $75K. The decline has persisted for multiple quarters.
Company posted a loss of $-1.2M over the last year, representing 1550.5% of revenue.
Debt of $6.8M is 655.2x the company's cash position of $10K.
Operating cash flow has been negative for 3 consecutive quarters, burning $173K over the last year.
Gross margin expanded by 8.8 percentage points, indicating improved pricing power or cost efficiency.
Operating margin expanded by 133.8pp, demonstrating strong operational leverage.
Both gross margin (+8.8pp) and operating margin (+133.8pp) are expanding simultaneously, indicating the company is scaling profitably.
Strong gross margin of 53.2% reflects healthy unit economics.
Valuation, risk assessment, competitive positioning, and key insights — all in one report.
Other Medical - Devices companies of a similar size
Based on 2026-Q3 (December 31, 2025)